Table 2.
Cancer Mortality Rate in CANTOS
| 300-mg Dose Group | Rate Reduction |
|---|---|
| Cancer mortality | 51% (p = 0.0009) |
| Lung cancer incidence | 67% (p < 0.0001) |
| Lung cancer mortality | 77% (p = 0.0002) |
Cancer Mortality Rate in CANTOS
| 300-mg Dose Group | Rate Reduction |
|---|---|
| Cancer mortality | 51% (p = 0.0009) |
| Lung cancer incidence | 67% (p < 0.0001) |
| Lung cancer mortality | 77% (p = 0.0002) |